Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3951
BlackRock ESG Capital Allocation Term Trust
ECAT
$1.53B
| $1.03M | ﹤0.01% |
65,871
-11,065
| -14% | -$171K |
|
3952
Bioventus
BVS
$945M
| $1.03M | ﹤0.01% |
356,536
-808,189
| -69% | -$1.55M |
|
3953
Tango Therapeutics
TNGX
$3.94B
| $1.03M | ﹤0.01% |
309,572
+111,409
| +56% | +$401K |
|
3954
Celcuity
CELC
$4.33B
| $1.03M | ﹤0.01% |
93,479
-298,688
| -76% | -$3.1M |
|
|
EA
3955
CALL
DELISTED
Electronic Arts
EA
| $1.02M | ﹤0.01% |
7,900
-23,700
| -75% | -$3M |
|
3956
Invesco
IVZ
$14.5B
| $1.02M | ﹤0.01% |
60,850
-29,201
| -32% | -$470K |
|
3957
Enerpac Tool Group
EPAC
$1.92B
| $1.02M | ﹤0.01% |
37,855
-268,462
| -88% | -$6.81M |
|
3958
MainStreet Bancshares
MNSB
$179M
| $1.02M | ﹤0.01% |
44,964
-56,840
| -56% | -$1.25M |
|
3959
Keurig Dr Pepper
KDP
$43.8B
| $1.02M | ﹤0.01% |
32,578
-1,573,738
| -98% | -$51.7M |
|
3960
FS Bancorp
FSBW
$337M
| $1.02M | ﹤0.01% |
33,866
-80,736
| -70% | -$2.37M |
|
3961
CALL
Zoom
ZM
$28.7B
| $1.02M | ﹤0.01% |
15,000
-29,800
| -67% | -$1.99M |
|
3962
Telefônica Brasil
VIV
$18.2B
| $1.02M | ﹤0.01% |
111,397
-215,344
| -66% | -$1.8M |
|
3963
iShares MSCI Chile ETF
ECH
$1.05B
| $1.02M | ﹤0.01% |
+34,835
| New | +$1.01M |
|
3964
CALL
State Street SPDR S&P Metals & Mining ETF
XME
$4.74B
| $1.02M | ﹤0.01% |
+20,000
| New | +$982K |
|
3965
United Fire Group
UFCS
$1.39B
| $1.02M | ﹤0.01% |
44,816
+35,458
| +379% | +$876K |
|
|
PRSU
3966
Pursuit Attractions and Hospitality Inc
PRSU
$1.36B
| $1.01M | ﹤0.01% |
37,755
-9,963
| -21% | -$221K |
|
3967
Apyx Medical
APYX
$130M
| $1.01M | ﹤0.01% |
201,572
+97,817
| +94% | +$496K |
|
3968
Univest Financial
UVSP
$1.15B
| $1.01M | ﹤0.01% |
55,986
-210,079
| -79% | -$4.11M |
|
|
BBT
3969
Beacon Financial Corp
BBT
$2.63B
| $1.01M | ﹤0.01% |
48,827
-164,567
| -77% | -$3.55M |
|
3970
PUT
Unisys
UIS
$196M
| $1.01M | ﹤0.01% |
253,200
+123,300
| +95% | +$489K |
|
|
ME
3971
DELISTED
23andMe Holding Co
ME
| $1.01M | ﹤0.01% |
28,758
+28,071
| +4,086% | +$1.12M |
|
3972
Instil Bio
TIL
$51.4M
| $1.01M | ﹤0.01% |
91,232
+26,373
| +41% | +$322K |
|
3973
Gilat Satellite Networks
GILT
$766M
| $1.01M | ﹤0.01% |
161,333
-431,415
| -73% | -$2.31M |
|
3974
Superior Group of Companies
SGC
$194M
| $1M | ﹤0.01% |
107,561
+46,806
| +77% | +$393K |
|
3975
CALL
Crown Castle
CCI
$32.4B
| $1M | ﹤0.01% |
8,800
-1,500
| -15% | -$179K |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.